HINODE研究からの機械学習分析を用いた心臓移植可能な電子機器を持つ心不全患者のリスク分層化と結果予測
Keijiro Nakamura1, Kazutaka Aonuma2, Torsten Kayser3
1Division of Cardiovascular Medicine, Toho University Ohashi Medical Center Tokyo Japan.
Circulation reports
|February 12, 2026
まとめ
機械学習モデルは,心臓器具を装着した日本の心不全患者の不良結果を正確に予測します. このアプローチはリスクの階層化を強化し,より良い患者管理のためのパーソナライズされた治療戦略をサポートします.
科学分野:
- 心臓病学 心臓病学
- 医療情報工学 医療情報工学
- 機械学習 (Machine Learning) とは,機械学習 (Machine Learning) について学ぶことです.
背景:
- 日本の高齢者層では,心不全 (HF) の罹患率が上昇しています.
- 植入可能なカーディオバーター・デフィブリレーターおよび心臓再同期療法の使用は,西欧諸国と比較して日本では低い.
- HINODE研究では,心臓器具を装着した日本人の患者のデータを将来的に収集しました.
研究 の 目的:
- 日本のHF患者におけるリスクの階層化を改善するために,解釈可能な機械学習 (ML) モデルを開発する.
- HF入院および全原因死亡率を含む有害な結果の主要な予測要因を特定する.
- 心臓器具を装着したHF患者の個別化された管理戦略を支援する.
主な方法:
- 適切なデータを持つ332人のHINODE参加者のデータを利用した.
- XGBoostを使用して5倍クロス検証で予測モデルを開発しました.
- 特徴の重要性に対するShapley Additive Explanations (SHAP) と,リスクの階層化のためのK-meansクラスタリングを採用した.
主要な成果:
- モデルでは,HFイベント (AUC 0.83) と死亡率 (AUC 0.85) の強い差別が示されました.
- 特定された主要な予測要因には,QRSの持続時間,QT間隔,左心室の体積,および薬が含まれています.
- 2つの異なるリスククラスターが特定されました:低リスク (n=236) と高リスク (n=86),イベント率が著しく異なります.
結論:
- 解釈可能なMLモデルは,リスクを正確に予測し,日本のHF患者におけるフェノタイプベースの分層化を可能にします.
- 発見は,心臓器具を装着したHF患者のパーソナライズされた管理のためにMLの使用を支持しています.
- このアプローチは,この増加する患者集団における治療戦略を最適化するのに役立ちます.
キーワード:
心臓再同期療法による心臓再同期療法です.心不全は,心不全によるものです.機械学習 (Machine Learning) とは,機械学習 (Machine Learning) というものです.リスクの階層化シェープリー添加物説明 (SHAP) 分析さらに関連する動画
03:47Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
1.2K
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.9K
関連する概念動画
02:24Predicting Reaction Outcomes
11.0K
Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
11.0K
01:29Heart Failure II: Pathophysiology
1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
01:17Pathophysiology of Heart Failure
4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
01:27Heart Failure I: Introduction
951
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
951
01:22Heart Failure VI: Adjunct Therapies
395
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
395
01:22Heart Failure Drugs: Diuretics
1.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K